EPO and kidney disorder: Several mechanisms are contributed to the onset and aggravation of anemia, including comorbid kidney diseases, blunted erythropoietin synthesis/response, hemodilution, cytokine-mediated inflammation, some guideline-recommended medications, and disturbances in iron metabolism [9–13, 25].